Abstract
APBI (accelerated partial-breast irradiation) treatments can be delivered using external beam or brachytherapy techniques. Interstitial brachytherapy using LDR (low-dose rate) Ir-192 seeds was historically the first modality used for APBI and consequently has the longest follow-up. More recently, external beam treatment has been used, either as photon, proton beams, or highly collimated electron beams, the latest being more often associated with intraoperative techniques relatively popular in Europe. New brachytherapy sources have been developed, including a miniature low-energy (~50 kV) electronic brachytherapy source and existent sources (e.g., Pd-103) commonly used as permanent seed implants for PBI, i.e., prostate cancer [47, 54, 56]. However, more commonly, APBI brachytherapy is associated with HDR (high-dose rate) treatment using Ir-192. The relatively high-energy source (~380 keV) at the tip of a thin wire is placed, using a computer-controlled afterloader device, in precisely specified positions for time intervals determined during the planning phase. Given the fact that the treatment is delivered very fast compared with the average half-time of cellular repair processes, one can establish equivalence between multiple sources loaded simultaneously (LDR) and one source, as is the basis for the HDR paradigm. Utilizing a planned combination of dwell positions, the single HDR source being successively placed in specified positions along applicators, and dwell times, and the specified time, the single HDR source remains at that position. Thus, after combining a well-determined target, a specified applicator, and a given strength of an Ir-192 source, an HDR treatment plan is generated through specifying dwell positions and their associated dwell times. The highly radioactive source cannot be placed in direct contact with tissues, and therefore, various devices or “applicators” are used to both contain and to guide the source in the desired positions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrassy M, Niatetsky Y, Perez-Calatayud J. Controversies. Co-60 versus Ir-192 in HDR brachytherapy: scientific and technological comparison. Rev Fis Med. 2012;13(2):125–30.
Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56:681–9.
Baglan KL, Sharpe MB, Jaffray D, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55(2):302–11.
Baltas D, Sakelliou L, Zamboglou N. The physics of modern brachytherapy for oncology. New York: Taylor & Francis; 2007.
Beaulieu L, Carlsson Tedgren A, Carrier JF, Davis SD, Mourtada F, Rivard MJ, Thomson RM, Verhaegen F, Wareing TA, Williamson JF. Report of the task group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. Med Phys. 2012;39(10):6208–36.
Brashears JH, Dragun AE, Jenrette JM. Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009;8(1):19–25.
Carlsson AK, Ahnesjö A. The collapsed cone superposition algorithm applied to scatter dose calculations in brachytherapy. Med Phys. 2000;27(10):2320–32.
Cheng CW, Mitra R, Li XA, Das IJ. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study. Med Phys. 2005;32(7):2279–87.
Cuttino LW, Todor D, Arthur DW. CT-guided multi-catheter insertion technique for partial breast brachytherapy: reliable target coverage and dose homogeneity. Brachytherapy. 2005;4(1):10–7.
Cuttino LW, Todor D, Pacyna L, Lin PS, Arthur DW. Three-dimensional conformal external beam radiotherapy (3D-CRT) for accelerated partial breast irradiation (APBI): what is the correct prescription dose? Am J Clin Oncol. 2006;29(5):474–8.
Cuttino LW, Todor D, Rosu M, Arthur DW. Skin and chest wall dose with multi-catheter and MammoSite breast brachytherapy: Implications for late toxicity. Brachytherapy. 2009;8(2):223–6.
Dickler A, Kirk MC, Coon A, Bernard D, Zusag T, Rotmensch J, Wazer DE. A dosimetric comparison of Xoft Axxent Electronic Brachytherapy and iridium-192 high-dose-rate brachytherapy in the treatment of endometrial cancer. Brachytherapy. 2008;7(4):351–4.
Durante M. New challenges in high-energy particle radiobiology. Br J Radiol. 2014;87(1035):20130626.
Jagsi R, Ben-David MA, Moran JM, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76(1):71–8.
Kassas B, Mourtada F, Horton JL, Lane RG. Contrast effects on dosimetry of a partial breast irradiation system. Med Phys. 2004;31(7):1976–9.
Livi L, Buonamici FB, Simontacchi G, et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 2010;77(2):509–15.
Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20(6):1709–19.
Monroe JI, Dempsey JF, Dorton JA, Mutic S, Stubbs JB, Markman J, Williamson JF. Experimental validation of dose calculation algorithms for the GliaSite RTS, a novel 125I liquid-filled balloon brachytherapy applicator. Med Phys. 2001;28(1):73–85.
Moon SH, Shin KH, Kim TH, et al. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity modulated radiotherapy, helical tomotherapy, and proton beam therapy. Radiother Oncol. 2009;90(1):66–73.
Munro JJ, Medich DC. Dosimetric comparison of three radiation sources used in balloon-based breast. Brachytherapy. 2007;6:80–81.
Oliver M, Chen J, Wong E, Van Dyk J, Perera F. A treatment planning study comparing whole breast radiation therapy against conformal, IMRT and tomotherapy for accelerated partial breast irradiation. Radiother Oncol. 2007;82(3):317–23.
Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, Suit HD. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):407–21.
Park CC, Yom SS, Podgorsak MB, Harris E, Price Jr RA, Bevan A, Pouliot J, Konski AA, Wallner PE, Electronic Brachytherapy Working Group. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):963–72.
Perez-Calatayud J, Ballester F, Das RK, Dewerd LA, Ibbott GS, Meigooni AS, Ouhib Z, Rivard MJ, Sloboda RS, Williamson JF. Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO. Med Phys. 2012;39(5):2904–29.
Pignol JP, Keller B, Rakovitch E, Sankreacha R, Easton H, Que W. First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2006;64(1):176–81.
Poon E, Verhaegen F. Development of a scatter correction technique and its application to HDR 192Ir multicatheter breast brachytherapy. Med Phys. 2009;36:3703–13.
Raffi JA, Davis SD, Hammer CG, Micka JA, Kunugi KA, Musgrove JE, Winston Jr JW, Ricci-Ott TJ, DeWerd LA. Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. Med Phys. 2010;37(6):2693–702.
Richardson SL, Pino R. Dosimetric effects of an air cavity for the SAVI partial breast irradiation applicator. Med Phys. 2010;37(8):3919–26.
Rivard MJ, Davis SD, DeWerd LA, Rusch TW, Axelrod S. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent x-ray source: an electronic brachytherapy source. Med Phys. 2006;33:4020–32.
Rivard MJ, Venselaar JL, Beaulieu L. The evolution of brachytherapy treatment planning. Med Phys. 2009;36(6):2136–53.
Rusch TW, Davis SD, DeWerd LA, Burnside RR, Axelrod S, Rivard MJ. Characterization of a new miniature x-ray source for electronic brachytherapy. Med Phys. 2004;31:1807.
Shah C, Badiyan S, Ben Wilkinson J, Vicini F, Beitsch P, Keisch M, Arthur D, Lyden M. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial. Ann Surg Oncol. 2013;20(10):3279–85.
Taghian AG, Kozak KR, Katz A, Adams J, Lu HM, Powell SN, et al. Accelerated partial breast irradiation using proton beams: initial dosimetric experience. Int J Radiat Oncol Biol Phys. 2006;65:1404–10.
Todor D, Becker S, Orton CG. Point/counterpoint. Brachytherapy is better than external beam therapy for partial breast irradiation. Med Phys. 2013;40(8):080601.
Vargo JA, Verma V, Kim H, Kalash R, Heron DE, Johnson R, Beriwal S. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity. Int J Radiat Oncol Biol Phys. 2014;88(2):285–91.
Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;57(5):1247–53.
Vicini F, Winter K, Straube W, et al. A phase I/II trial to evaluate three dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys. 2005;63(5):1531–7.
Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: do uncertainties outweigh potential benefits? Br J Radiol. 2013;86(1029):20130176.
Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006;64(2):489–95.
White SA, Landry G, Fonseca GP, Holt R, Rusch T, Beaulieu L, Verhaegen F, Reniers B. Comparison of TG-43 and TG-186 in breast irradiation using a low energy electronic brachytherapy source. Med Phys. 2014;41(6):061701.
Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Phys Med Biol. 1995;40(9):1435–49.
Yu CX, Li XA, Ma L, et al. Clinical implementation of intensity modulated arc therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):453–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Todor, D.A. (2016). Physics of APBI. In: Arthur, D., Vicini, F., Wazer, D., Khan, A. (eds) Short Course Breast Radiotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-24388-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-24388-7_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24386-3
Online ISBN: 978-3-319-24388-7
eBook Packages: MedicineMedicine (R0)